Revelation Biosciences, Inc. (REVB)
NASDAQ: REVB · Real-Time Price · USD
0.764
+0.006 (0.74%)
Nov 21, 2024, 10:31 AM EST - Market open
Revelation Biosciences Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Nov '24 Nov 21, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 1 | 3 | 4 | 67 | 93 |
| Market Cap Growth | -67.76% | -29.53% | -93.31% | -28.41% | - |
| Enterprise Value | -5 | -11 | -2 | 70 | - |
| Last Close Price | 0.76 | 15.02 | 199.61 | 10710.02 | 10552.52 |
| PB Ratio | 1.22 | 0.47 | 4.25 | -671.97 | 27.37 |
| P/TBV Ratio | 0.52 | 0.47 | 4.25 | - | 31.04 |
| Debt / Equity Ratio | - | - | - | -0.17 | - |
| Quick Ratio | 1.61 | 2.15 | 1.18 | 0.60 | 3.72 |
| Current Ratio | 1.64 | 2.18 | 1.22 | 0.89 | 3.82 |
| Return on Equity (ROE) | -270.02% | -3.12% | -2272.77% | -723.81% | - |
| Return on Assets (ROA) | -50.98% | -61.08% | -179.98% | -224.21% | - |
| Return on Capital (ROIC) | -92.97% | -140.53% | -1400.45% | -448.74% | - |
| Earnings Yield | -1244.24% | -3.81% | -242.05% | -17.93% | -4.07% |
| FCF Yield | -1332.26% | -231.09% | -250.76% | -16.79% | -2.28% |
| Buyback Yield / Dilution | -525.77% | -215.00% | - | - | - |
| Total Shareholder Return | -525.77% | -215.00% | - | - | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.